Oxycodone Hydrochloride Tablet
NDC Package 47781-263-01
Package Information
Oxycodone Hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. This formulation utilizes a tablet delivery system. Marketed by Alvogen, Inc., this product is identified by NDC 47781-263 and is authorized under FDA application ANDA202116.
Identification & Billing
- RxCUI: 1049611 - oxyCODONE HCl 15 MG Oral Tablet
- RxCUI: 1049611 - oxycodone hydrochloride 15 MG Oral Tablet
- RxCUI: 1049618 - oxyCODONE HCl 30 MG Oral Tablet
- RxCUI: 1049618 - oxycodone hydrochloride 30 MG Oral Tablet
- RxCUI: 1049621 - oxyCODONE HCl 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 47781 - Alvogen, Inc.
- 47781-263 - Oxycodone Hydrochloride
- 47781-263-01 - 100 TABLET in 1 BOTTLE
- 47781-263 - Oxycodone Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (47781-263). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 47781-263-01 identifies a specific commercial package of 100 tablet in 1 bottle of Oxycodone Hydrochloride, a human prescription drug labeled by Alvogen, Inc.. This tablet is formulated for oral use and contains oxycodone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alvogen, Inc. on December 30, 2011. The current certification is valid through December 31, 2027.
How is this Alvogen, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 47781026301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.